Print Page | Sign In
Merrick I. Ross, MD
Share |

Merrick I. Ross, MD, is Professor of Surgery and Chief of the Melanoma Section in the Department of Surgical Oncology at the University of Texas M.D. Anderson Cancer Center in Houston, Texas.

He received his medical degree from the University of Illinois School of Medicine in Chicago, completed a residency in general surgery at the University of Illinois Affiliated Hospitals in Chicago, and was administrative chief resident at the University of Illinois Department of Surgery. Additionally, Dr. Ross served a research fellowship at Scripps Clinic and Research Institute in La Jolla, CA, and completed both an administrative and a surgical oncology fellowship at the University of Texas M.D. Anderson Cancer Center.

Dr. Ross is well-published in medical literature and lectures extensively both domestically and abroad. He has also been the recipient of various awards, including the Charles M. McBride Distinguished Professorship in Surgical Oncology.


Surgical Approach to Melanoma


  1. Update on different surgical approaches in the treatment of melanoma
  2. Recognize the use of different surgical techniques in the treatment of melanoma


  1. New methods of diagnosis or treatment
  2. Advances in medical knowledge


  1. Bolognia, Jorizzo, et al, Dermatology 2nd edition, 2008. Pgs. 2270-2.
  2. Willey, A., Papdopoulos D, et al. “Modified Single-Sling Mycutaneous Island Pedicle Flap: Series of 61 Reconstructions.” Dermatologic Surgery 2008;34:1527-1535.
  3. Martinez J, Cook J, Otley C. “The Keystone Fasciocutaneous Flap in the Reconstruction of Lower Extremity Wounds.” Dermatologic Surgery 2012;38:484-489.

Core Competencies: 2, 3, 5, 6


Case Studies in Melanoma: An Interactive Panel

This lecture will be an interactive discussion of complex melanoma patients with a panel of experts and the attendees.


  1. Review and discuss of complex melanoma patients from a diagnostic standpoint
  2. Review and discuss treatment alternatives in treating complex melanoma patients
  3. Invite audience participation through discuss of complex cases from the practice


  1. New advances in dermatologic treatment
  2. New methods of diagnosis or treatment
  3. Availability of new medication(s) or indication(s)


  1. M.B. Faries, et al. “Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.” N Engl J Med, 2017 June 8; 376(23): 2211-2281.
  2. NCCN Clinical Practice Guidelines in Oncology. “Melanoma”. 2016, Nov 10; Version 1.2017.

Core competencies: 2, 3, 4, 6

Disclosures: Advisory Board Member: Merck, Amgen, GSK; Consultant: GSK; Speaker: Provectus

2902 North Baltimore Street | P.O. Box 7525 | Kirksville, Missouri 63501

660-665-2184 | 1-800-449-2623 | 660-627-2623